Aurobindo Pharma consolidated net profit rises 25.20% in the June 2026 quarter
(06 Aug 2026)
Back
Net profit of Aurobindo Pharma rose 25.20% to Rs 1032.56 crore in the quarter ended June 2026 as against Rs 824.75 crore during the previous quarter ended June 2025. Sales rose 16.86% to Rs 9105.82 crore in the quarter ended June 2026 as against Rs 7791.77 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | | Jun. 2026 | Jun. 2025 | % Var. |
| Sales | 9105.82 | 7791.77 | 17 |
| OPM % | 20.64 | 20.57 | - |
| PBDT | 2042.09 | 1612.50 | 27 |
| PBT | 1555.27 | 1206.80 | 29 |
| NP | 1032.56 | 824.75 | 25 |
|